Conferences

25–26 April 2012, Singapore, Singapore
2nd Annual Biomarkers in Diagnostics & Therapeutics

Biomarker has become a buzz word in both the pharmaceuticals and diagnostics sectors within the last few years, with promising results in pharmacogenomics studies and molecular diagnostics; and especially in the field of drug-diagnostic co-development where it’s potential in companion diagnostics have been fuelling the ultimate promise of a future towards personalised healthcare.

2nd Annual BDT2012 endeavours to grow the discussion further by congregating the insights of leaders from the diagnostics, pharmaceuticals, medical and academic fields to evaluate developments that have materialised from the promise of biomarker R&D. We will review progresses in areas of companion diagnostics, clinical drug development and in personalising treatment options with a reality check on translating biomarker studies into clinical practice. Key hurdles in biomarker identification and validation will be handled, while technological solutions, new research targets and discovery strategies aiding in the translation of biomarker towards bedside applications will be critically examined.

http://www.eventprotocol.com/bdt2012.php

Back to TopTop